Onconova Therapeutics (ONTX), Vaxart (VXRT), Agile Therapeutics (AGRX) and Idera Pharmaceuticals StockTwits is a social, stock micro-blogging service.

2021-02-03

Analyzing Vaxart (NASDAQ:VXRT) stock? View VXRT's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at Vaxart Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections th Vaxart Inc. NASDAQ:VXRT 1:52:16 PM EDT. 6.91. +0.17 (+2.52%).

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Description: Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. Vaxart (NASDAQ:VXRT) The company is working on a vaccine for the novel coronavirus that works via tablets instead of injection.

The company is working on a vaccine for the novel coronavirus that works via tablets instead of injection. Earnings for Vaxart are expected to grow in the coming year, from ($0.35) to ($0.30) per share.

Get the latest Vaxart, Inc. - Common Stock (VXRT) stock news and headlines to help you in your trading and investing decisions.

The P/E ratio of Vaxart is -9.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Price to … VXRT, $VXRT, Vaxart Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators We have 9 different ratings for every stock to help you appreciate its future potential.

Latest VAXART (VXRT) stock news, Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of Close. Discover the power of Social Financial News! Get all the latest news for all your Stocktwits watchlist symbols in one click!

02/24/21. Vaxart to Provide 2021 Business Outlook on Tuesday, March 2, 2021.. Read 2021-04-09 2019-11-13 Vaxart Stock Trades Higher On Increased Volume: A Technical Analysis. Vaxart Inc. (NASDAQ: VXRT) shares gained 2.69% Tuesday on increased volume, closing the session at $7.06.

2021-04-09 2021-01-16 Find the latest news headlines from Vaxart, Inc Common Stock (VXRT) at Nasdaq.com. 2020-02-25 2021-04-09 Vaxart Inc. (NASDAQ: VXRT) shares gained 2.69% Tuesday on increased volume, closing the session at $7.06. The stock was trending on StockTwits, and there was no company evident news to … Vaxart, Inc. Headquarters. 170 Harbor Way, Suite 300, South San Francisco, CA 94080 +1 650 550 3500 MAIN +1 650 871 8580 FAX vxrt stocktwits, Feb 20, 2020 · Company’s new Logix Smart™ COVID-19 Test expected to be available with CE marking in February 2020 Salt Lake City, Utah – February 20, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ COVID-19 Test technical file 2021-03-26 2020-08-07 The global vaccine market is growing steadily, and Vaxart is developing next-generation oral vaccines that could replace injectable vaccines, target new diseases, and have a major impact on the never-ending battle of the human race with infectious diseases all across … March 4, 2021 - 4:01 pm. SOUTH SAN FRANCISCO, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that management will present at the H.C. Wainwright Global Life Sciences Conference taking place on March 9-10, 2021. Vaxart Inc. Trial Registration: ClinicalTrials.gov NCT02868073.
Postnord inlämning liljeholmen

ET by Jaimy Lee Vaxart's stock rises 2.4% premarket, after rocketing 72% on Friday We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now. A high-level overview of Vaxart, Inc. (VXRT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

StockTwits / Trade App, Vaxart Inc, NASDAQ https://stocktwits.com/symbol/VXRT.
Horselskadade skylt

the globalization of world politics. an introduction to international relations
music studio space for rent
hur man blir sjuk snabbt
medicinsk undersökning adhd
fast egendom gifta

Find the latest Vaxart, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, GSK and the UK

Share your opinion and gain insight from other stock traders and investors. 2021-03-30 · Vaxart, Inc Common Stock (VXRT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Vaxart, Inc. VXRT Stock Message Board: Here is a copy and paste from Stocktwits. Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform.

Danska ord i svenskan
mr cool knulla

VXRT, $VXRT, Vaxart Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators

Rooms Shows Rankings Earnings Calendar Shop. Cancel. Log In. Sign Up. DOW 0.00%. S&P 500 0.00%. NASDAQ 0.00%.